Keyphrases
Finland
100%
Type 1 Diabetes Mellitus (T1DM)
87%
Type I Diabetes
86%
Confidence Interval
82%
Islet Autoimmunity
68%
Randomized Controlled Trial
66%
Uganda
62%
Human Adipose-derived Stem Cells (hADSCs)
41%
Low Birth Weight
41%
Diabetes
38%
Lipid Supplementation
35%
High Risk
35%
Older children
34%
Etiology
34%
Type 2 Diabetes Mellitus (T2DM)
32%
Severe Malnutrition
32%
Celiac Disease
32%
Transient Receptor Potential Vanilloid 1 (TRPV1)
31%
Clinical Trials
29%
Ready-to-use Therapeutic Food
29%
Prospective Cohort Study
28%
Population-based Study
28%
Bioactive Glass
27%
Odds Ratio
27%
Mid-upper Arm Circumference
27%
Malawi
27%
Meta-analysis
26%
Hazard Ratio
26%
Inflammation
26%
Azithromycin
26%
Stunted children
25%
Antenatal Intervention
25%
University Hospital
24%
Small-for-gestational Age
24%
Single Center
24%
Mali
24%
DNA Methylation (DNAm)
24%
Environmental Determinants
24%
Tampere
24%
Obesity
23%
In Vitro Biocompatibility
23%
Rural Malawi
23%
Hip Fracture
23%
Bioactive Glass Scaffolds
23%
Rheumatic Diseases
23%
Low-middle Income Countries
23%
Body Composition
22%
Prostate Cancer
21%
Older Adults
21%
Young children
21%
Cell Culture
20%
Risk Factors
20%
Vegetables
20%
Kenya
19%
Young Finns Study
19%
Body Mass Index
19%
Dietary Intake
19%
Linear Growth
19%
Child nutrition
19%
Gluten
18%
Overall Survival
18%
Child Growth
18%
Physical Activity
18%
Height-for-age Z-score
18%
During Pregnancy
18%
Autoantibodies
18%
Milk Protein
18%
Micronutrient Status
18%
Weight-for-age z Score
18%
Pregnant Women
17%
Anxiety-depression
17%
High-risk Human Papillomavirus (HR-HPV)
17%
Prognostic Factors
17%
Cognitive Performance
17%
Urinary Incontinence
17%
Bone Regeneration
17%
Tissue Engineering
17%
Whey Permeate
17%
Fasting Plasma Glucose
17%
Preterm Birth
17%
Stem Cell-derived
16%
Myopathy
16%
Depressive Symptoms
16%
Prognostic Value
16%
Tanzania
16%
Psychosocial Support
16%
Biobank
16%
Retrospective Cohort Study
16%
Nationwide Register Study
16%
Stillbirth
16%
Mortality Risk
15%
Bacteremia
15%
Human Mesenchymal Stem Cells (hMSCs)
15%
Randomized Placebo-controlled Trial
15%
Borosilicate Bioactive Glass
15%
In Vitro Dissolution
15%
Corneal Stroma
15%
CpG Sites
15%
Milk Whey
15%
Measurement Practices
15%
Medicine and Dentistry
Arm
63%
Randomized Controlled Trial
57%
Diseases
55%
Neonatal Infant
49%
Systematic Review
48%
Wart Virus
46%
Insulin Dependent Diabetes Mellitus
46%
Tissue Regeneration
44%
Adipose Tissue
39%
Prevalence
39%
Autoimmunity
39%
Stem Cell
38%
Malignant Neoplasm
37%
Meta-Analysis
33%
Cohort Analysis
31%
Prostate Cancer
30%
Odds Ratio
29%
Low Birth Weight
29%
Health Care Cost
27%
Diabetes
27%
In Vitro
26%
Biological Marker
25%
Blood Pressure
25%
Maturity Onset Diabetes of the Young
25%
Premature Labor
24%
Hip Fracture
23%
Retrospective Cohort Study
23%
Azithromycin
23%
Ascorbic Acid 2 Phosphate
23%
Streptococcus Dysgalactiae
23%
Bloodstream Infection
23%
Prospective Study
23%
Clinical Trial
23%
Prospective Cohort Study
22%
Infection
22%
Radiation Therapy
21%
Low and Middle Income Countries
21%
Overall Survival
21%
Cross Sectional Study
20%
Placebo
20%
Induced Pluripotent Stem Cell
20%
Stromal Cell
20%
Pulse Wave Velocity
20%
Physical Activity
19%
Restylane
19%
Small for Gestational Age
19%
Stroma of Cornea
18%
Quality of Life
18%
Offspring
17%
Hemodynamic
17%
Supplementation
17%
Coronary Artery Disease
17%
Drug Administration
15%
Dysplasia
15%
Prognostic Factor
15%
Hepatocyte
15%
Alzheimer's Disease
15%
Drug Response
15%
Diet Supplementation
15%
Therapeutic Use
15%
Rheumatic Disease
15%
Pelvic Organ Prolapse
15%
Primary Health Care
15%
Systemic Vascular Resistance
15%
Cancer
15%
Autoantibodies
15%
Urine Incontinence
15%
Enuresis
15%
Disease Severity
14%
Cardiovascular System
14%
Nutrition
13%
Osteoarthritis
13%
Surgery
13%
Cell Culture
13%
Subgroup Analysis
13%
Body Mass Index
12%
Stunting
12%
Hazard Ratio
12%
Splinting
11%
Heart Work
11%
Leukemia
11%
Human Tissue
11%
Ex Vivo
11%
Biocompatible Material
11%
Observational Study
11%
Stillbirth
11%
Gestational Age
11%
T-Helper Cell
11%
Malnutrition
11%
Secondary Data
10%
Logistic Regression Analysis
10%
Breast Cancer
10%
Gestational Diabetes
10%
Urinary System
10%
Pre-Eclampsia
10%
Obesity
10%
Lipid Metabolism
10%
Birth Outcomes
10%
Diagnosis
10%
Autoimmune Disease
10%